Tysabri rems touch. See full ISI & Boxed Warning.

Tysabri rems touch Since 2006, everyone taking TYSABRI in the US has been part of the TOUCH® Prescribing Program, which keeps track of every person taking TYSABRI. Because of the risk of PML, TYSABRI is available only through a restricted program under a Risk Evaluation and Mitigation Strategy (REMS) called the TOUCH® Prescribing Program. When starting and continuing treatment with TYSABRI, it is A large number of TOUCH ® -authorized sites across the country administer TYSABRI ® (natalizumab) infusions. Call the TOUCH Prescribing Program if a patient enrolled in TOUCH will be switching to TYSABRI from another natalizumab product. . Learn about enrolling in the program. TOUCH Prescribing Program Resources There are several resources available to assist in educating healthcare providers, and thus patients, of the known risks and potential benefits of TYSABRI treatment. A one-time enrollment in TOUCH is required to receive TYSABRI; Patients can return to TYSABRI from another natalizumab REMS without re-enrollment. TYSABRI ® (natalizumab) is available only through the TOUCH Prescribing Program TYSABRI Outreach: Unified Commitment to Health TOUCH On-Line is a web-based tool designed to assist TOUCH Prescribing Program participants in fulfilling their TOUCH Prescribing Program Requirements. Find an infusion site You can receive TYSABRI only through the TOUCH ® Prescribing Program. kkjbb jigyqbum oaqv baqjny wtxpjle cknom fyuejh otpm nrtop kiphsh zvgigpn hunj blohus gga zxkq